The Efficacy of Berberine-Containing Quadruple Therapy on Helicobacter Pylori Eradication in China: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Future perspective for potential Helicobacter pylori eradication therapies

(2018) Ayla Debraekeleer et al.   Future Microbiology

Prevalence of antibiotic resistance in Helicobacter pylori : a systematic review and meta-analysis in World Health Organization regions

(2018) Alessia Savoldi et al.   GASTROENTEROLOGY

Fifth Chinese National Consensus Report on the management of Helicobacter pylori infection

(2018) Wen Zhong Liu et al.   HELICOBACTER

Berberine demonstrates anti-inflammatory properties in Helicobacter pylori -infected mice with chronic gastritis by attenuating the Th17 response triggered by the B cell-activating factor

(2018) Xiuxia Wu et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Influence of Helicobacter pylori infection on periodontitis

(2018) Kyoichi Adachi et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Current Helicobacter pylori infection is significantly associated with subclinical coronary atherosclerosis in healthy subjects: A cross-sectional study

(2018) Minyoung Lee et al.   PLoS One

Epiberberine, a natural protoberberine alkaloid, inhibits urease of Helicobacter pylori and jack bean: Susceptibility and mechanism

(2017) Lihua Tan et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen

(2017) Evrim Kahramanoğlu Aksoy et al.   MEDICAL PRINCIPLES AND PRACTICE

Berberine containing quadruple therapy for initial Helicobacter pylori eradication

(2017) Di Zhang et al.   MEDICINE

Berberine Attenuates Intestinal Mucosal Barrier Dysfunction in Type 2 Diabetic Rats

(2017) Jing Gong et al.   Frontiers in Pharmacology

How to Effectively Use Bismuth Quadruple Therapy

(2015) David Y. Graham et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

Berberine-loaded targeted nanoparticles as specificHelicobacter pylorieradication therapy:in vitroandin vivostudy

(2015) Yu-Hsin Lin et al.   Nanomedicine

Comparison of Helicobacter pylori Urease Inhibition by Rhizoma Coptidis, Cortex Phellodendri and Berberine: Mechanisms of Interaction with the Sulfhydryl Group

(2015) Cailan Li et al.   PLANTA MEDICA

Inhibitory effects of emodin, baicalin, schizandrin and berberine onhefAgene: Treatment ofHelicobacter pylori-induced multidrug resistance

(2015) Yan-Qiang Huang   WORLD JOURNAL OF GASTROENTEROLOGY

Helicobacter pylorivirulence genes and host genetic polymorphisms as risk factors for peptic ulcer disease

(2015) Muhammad Miftahussurur et al.   Expert Review of Gastroenterology & Hepatology

Prevalence ofHelicobacter pyloriInfection and its Relation with Body Mass Index in a Chinese Population

(2014) Chengfu Xu et al.   HELICOBACTER

Epidemiology ofHelicobacter pyloriInfection

(2014) Leonardo H. Eusebi et al.   HELICOBACTER

Treatment ofHelicobacter pyloriinfection: Meeting the challenge of antimicrobial resistance

(2014) Vasilios Papastergiou   WORLD JOURNAL OF GASTROENTEROLOGY

Treatment ofHelicobacter pyloriinfection: Current status and future concepts

(2014) Jyh-Chin Yang   WORLD JOURNAL OF GASTROENTEROLOGY

Eradication of Helicobacter pylori Infection Reduces the Incidence of Peptic Ulcer Disease in Patients using Nonsteroidal Anti-Inflammatory Drugs: A Meta-Analysis

(2012) Chun-Li Tang et al.   HELICOBACTER

Development of novel nanoparticles shelled with heparin for berberine delivery to treat Helicobacter pylori

(2010) Chiung-Hung Chang et al.   Acta Biomaterialia